DZ Bank
SRPT icon

DZ Bank’s Sarepta Therapeutics SRPT Stock Holding History

DZ Bank’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.3K Buy
+3,024
New +$57.2K ﹤0.01% 1035
2018
Q2 		– Sell
-17,300
Closed -$1.28M – 1067
2018
Q1 		$1.28M Buy
+17,300
New +$1.15M 0.01% 607

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DZ Bank's SRPT Position: Q2 2026 in Review

DZ Bank opened a new position in Sarepta Therapeutics (SRPT) in Q2 2026: 3,024 shares worth $54.3K. The stake represents ﹤0.01% of the portfolio and ranks #1035 among its holdings. This is a return to the name: DZ Bank previously reported a position in SRPT as recently as Q1 2018.

DZ Bank first reported a position in SRPT in Q1 2018 and has held it in 2 quarters since. The position peaked at $1.28M in Q1 2018. 324 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • DZ Bank held 3,024 shares of Sarepta Therapeutics worth $54.3K as of Q2 2026.
  • Sarepta Therapeutics was a new DZ Bank position in Q2 2026.
  • Sarepta Therapeutics made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #1035 holding.
  • DZ Bank first reported a position in Sarepta Therapeutics in Q1 2018 and has held it in 2 quarters since.
  • DZ Bank's Sarepta Therapeutics position peaked at $1.28M in Q1 2018.
  • 324 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.